Cytomegalovirus Infection Cmv clinical trials

Explore recruiting cytomegalovirus infection cmv clinical trials.

Recruiting cytomegalovirus infection cmv studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cytomegalovirus Infection Cmv trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Finland, Italy, Spain, France, Belgium, Germany +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cytomegalovirus Infection Cmv trials by city

Cytomegalovirus Infection Cmv clinical trials

Recruiting cytomegalovirus infection cmv studies right now

Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Also recruiting in Europe

A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Cytomegalovirus Infection Cmv trials by city

Other conditions